Identification of subsets of IDH-mutant glioblastomas with distinct epigenetic and copy number alterations and stratified clinical risks

BACKGROUND: IDH-mutant glioblastoma is classified by the 2016 CNS WHO as a group with good prognosis. However, the actual number of cases examined in the literature is relatively small. We hypothesize that IDH-mutant glioblastoma is not a uniform group and should be further stratified. METHODS: We c...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Neurooncol Adv
Asıl Yazarlar: Li, Kay Ka-Wai, Shi, Zhi-Feng, Malta, Tathiane M, Chan, Aden Ka-Yin, Cheng, Shaz, Kwan, Johnny Sheung Him, Yang, Rui Ryan, Poon, Wai Sang, Mao, Ying, Noushmehr, Houtan, Chen, Hong, Ng, Ho-Keung
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Oxford University Press 2019
Konular:
Basic and Translational Investigations
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6798792/
https://ncbi.nlm.nih.gov/pubmed/31667475
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/noajnl/vdz015
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller